RxDoctor Payments Data

Jared Beck, DO

Gastroenterology · Palmer, AKNPI 1447678586

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 33.9% of the total. Reporting peaked in 2019 at $635 and has fallen 75.0% since, to $159 in 2025.

$2,103in general payments, 2019–2025

Across 27 payments — averaging $77.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$713
  • Medtronic$371
  • Mallinckrodt Hospital Products Inc.$217
  • Boston Scientific$131
  • AstraZeneca$128
  • Olympus America Inc.$125
  • plus $419 from 4 others

What the payments were for

  • Food & beverage$2,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,103 in reported general payments places this provider in the 75th percentile of 23 gastroenterology providers in Alaska.

See all gastroenterology providers in Alaska

Medicare billing

Part B allowed, 2024
$17,087
Medicare patients
64
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Palmer

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →